India Equity Analysis, Reports, Recommendations, Stock Tips and more!
Search Now
Recommendations
Thursday, January 14, 2016
Celestial Biolabs plans to manufacture 21 Allopathic drugs
Drug maker Celestial Biolabs Ltd on Wednesday said it has decided to introduce manufacturing and marketing of 21 life saving drugs in Allopathic range. The company is already manufacturing and marketing premium products in Herbal and Nutraceuticals range. In a filing to the Bombay Stock Exchange, the company said, “We are already manufacturing and marketing premium products in Herbal and Nutraceuticals range. In view of our established marketing & distribution network in India, we have decided to introduce manufacturing and marketing of 21 life saving drugs in Allopathic range covering - antibiotics, analgesic & anti-pyretics; antiulcerants; anti-hypertensives; anti-diabetics; anti-fungal; anti-allergic; anti-emetic; calcium supplement; steroid; immune suppressant and topical application for wound infection & neurological disorders.” “This will enhance our business sales volume & profitability in the times to come,” it added. Meanwhile, shares of the company closed at Rs 32 apiece, down 9.86 per cent, from previous close on BSE.